See what members are saying about kidney disease treatments, the side effects to expect, and the drug basics.
All treatment information is medically reviewed · July 14, 2026
Tarpeyo (budesonide) is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to reduce the loss of kidney function in adults with primary immunoglobulin A nephropathy (IgAN) who are at risk for their disease getting worse.
Become a member to get even more